Skip to Main Content
877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
877-YALEMDS
ALL KEYWORDS

Urothelial Carcinoma, Transitional Cell Carcinoma

Related Specialists

Showing 3 of 33
  • Joseph Brito

    MD
  • Michael Hurwitz

    MD, PhD
  • Thomas V. Martin

    MD
More Related Specialists

Related Fact Sheets

  • Transitional Cell Cancer of the Renal Pelvis and Ureter

  • Jelmyto®

Related Clinical Trials

Showing 2 of 3
  • A Phase 2, Randomized, Multi-center, Open Label Trial to Evaluate the Safety and Efficacy of Intravesical Nadofaragene Firadenovec Alone or in Combination with Chemotherapy or Immunotherapy in Participants with High-grade Bacillus Calmette-Guerin Therapy (BCG) Unresponsive Non-muscle Invasive Bladder Cancer (NMIBC)

    • Bladder Cancer
    • A Phase 1/2 Study to Investigate the Safety, Pharmacokinetics, and Efficacy of CRB-701, an Antibody-drug Conjugate Targeting Nectin-4, in Patients With Advanced Solid Tumors

      • Prostate Cancer
      • Bladder Cancer
      More Related Clinical Trials

      Related Departments

      Showing 3 of 11
      • Prostate & Urologic Cancers Program

      • Urology

      • Lower Urinary Tract Dysfunction (LUTD) & Genitourinary Reconstruction

      More Related Departments
      • About Us
      • Contact Us
      • Donate
      • Referring Doctors
      • Clinical Keywords

      333 Cedar St.

      New Haven, CT 06510

      • Yale School of Medicine
      • Yale University
      • Terms & Privacy Policies
      • Accessibility at YSM
      • Patient Rights
      • HIPAA at Yale
      • Non-discrimination Statement
      Copyright 2026 Yale Medicine